Skip to main content
. Author manuscript; available in PMC: 2012 Jan 6.
Published in final edited form as: Psychophysiology. 2011 Feb;48(2):285–291. doi: 10.1111/j.1469-8986.2010.01060.x

Table 1.

Demographic and Clinical Characteristics.

Variable Patients with Major Depressive Disorder
Healthy Subjects (N=91)
Medication-free (N=50) Hypnotics (N=50) Total (N=100)
Age, years 41.5 ± 12.9 44.2 ± 10.0 42.9 ± 10.7 42.1 ± 12.6
Gender, Male/Female 23/37 14/36 37/63 34/57
Type of benzodiazepine used
 Short-acting, N (%) 32 (64) 32 (32)
 Intermediate, N (%) N/A 25 (50) 25 (25) N/A
 Long-acting, N (%) 24 (48) 24 (24)
Beck Depression Inventory 20.7 ± 14.9* 33.3 ± 14.1* 27.2 ± 15.7* 6.1 ± 6.6
Hamilton Depression Rating Scale, 17 items 14.3 ± 8.1* 16.8 ± 7.9* 15.6 ± 8.1* 1.7 ± 2.6

Pittsburgh Sleep Quality Index 11.8 ± 4.0* 14.0 ± 3.6* 13.0 ± 4.0* 4.7 ± 2.9
Epworth Sleepiness Scale 9.1 ± 5.9 7.2 ± 6.5 8.1 ± 6.3 9.1 ± 5.1
Insomnia score derived from Beck Depression Inventory (item #16) 1.5 ± 1.1* 2.0 ± 0.9* 1.8 ± 1.1* 0.4 ± 0.7
Insomnia score derived from Hamilton Depression Rating Scale (item #4–6) 3.0 ± 1.8* 3.3 ± 2.0* 3.1 ± 1.9* 0.4 ± 0.8

N/A: not applicable.

Data represent mean ± 1 standard deviation unless otherwise noted.

Asterisk indicates statistical significance (p<0.05) compared with healthy controls.